Beijing, China

Chang Lu

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: **Inventor Chang Lu: Pioneering Innovations in Pharmaceutical Development**

Introduction

Chang Lu is a prominent inventor based in Beijing, China, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of five patents, he has made strides in developing compounds that have the potential to impact medical treatments.

Latest Patents

Among his recent accomplishments, Chang Lu has patented the iminosulfanone compound as a bromodomain protein inhibitor. This invention focuses on a specific compound, represented by a particular formula, which acts as a bromodomain protein inhibitor. It also includes the development of a pharmaceutically acceptable salt, its preparation method, pharmaceutical composition, and medical applications. Another notable patent involves a display screen or portion thereof featuring a graphical user interface, showcasing his versatile expertise in technology and health sectors.

Career Highlights

Chang Lu has had an impressive career that includes significant roles at esteemed institutions such as China University of Mining and Technology and Shenzhen University. His work at these universities has allowed him to influence research and innovation in the pharmaceutical domain.

Collaborations

Throughout his career, Chang has collaborated with notable colleagues, including Yang Ju and Yan Zhu. These partnerships have enabled the advancement of various research projects and innovations, further establishing his reputation as a leading inventor in his field.

Conclusion

In summary, Chang Lu’s contributions through his patents reflect a dedication to advancing medical science and technology. His patented inventions not only showcase his innovative spirit but also contribute valuable solutions for future healthcare challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…